Therapeutic Vaccines Market by Product Type, Distribution Channel, End User 2024-2032

1
Global Therapeutic Vaccines Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Therapeutic Vaccines Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global therapeutic
  vaccines market size reached US 31.3 Billion in
  2023.
• Therapeutic vaccines are immunotherapy designed
  to treat existing diseases. They work by
  stimulating or boosting the immune system of the
  body to recognize and fight specific pathogens or
  abnormal cells, such as cancer cells.
• They target diseases that a person already has as
  compared to preventive vaccines, which aim to
  protect individuals from contracting specific
  infectious diseases. They target and treat
  conditions caused by the virus, such as
  precancerous lesions.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/therapeutic-vaccines-ma
  rket/requestsample

4
Report Description

• Global Therapeutic Vaccines Market Trends
• The surging prevalence of contagious infections,
  such as human immunodeficiency virus (HIV), human
  papillomavirus (HPV), and acquired immune
  deficiency syndrome (AIDS), represents one of the
  major factors catalyzing the demand for
  therapeutic vaccines around the world. Moreover,
  the increasing number of airborne diseases due to
  the rising air pollution levels is augmenting the
  growth of the market.
• In addition, the growing number of clinical
  trials by pharmaceutical companies to improve
  therapeutic vaccines that offer long-lasting
  effects on immunization is influencing the market
  positively. Apart from this, continual
  technological advancements in the vaccine
  production process are strengthening the growth
  of the market.
• Looking forward, the market value is projected to
  reach US 71.4 Billion by 2032, expanding at a
  CAGR of 9.5 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/therapeutic-vaccines-ma
  rket

5
Report Segmentation

• Breakup by Type
• Antigen Vaccines
• Dendritic Cell Vaccine
• DNA Vaccine
• Tumor Cell Vaccines
•  
• Breakup by Disease Type
• Autoimmune Disease Vaccines
• Addiction Vaccine
• Neurological Disease Vaccine
• Infectious Disease Vaccine
• Others
• Breakup by Technology
• Autologous Vaccines

6
Report Segmentation

• Allogeneic Vaccine
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Agenus Inc.
• Argos Therapeutics Inc.
• Bavarian Nordic A/S
• Cel-Sci Corporation
• CSL Limited
• Emergent Biosolutions Inc.
• GSK plc
• Merck Co. Inc.
• Pfizer Inc.
• Sanofi S.A.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Therapeutic Vaccines
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type    6.1    Antigen
  Vaccines        6.1.1 Market Trends       
  6.1.2 Market Forecast    6.2    Dendritic Cell
  Vaccine        6.2.1 Market Trends        6.2.2
  Market Forecast    6.3    DNA Vaccine       
  6.3.1 Market Trends        6.3.2 Market
  Forecast       

10
Table of Contents

•     6.4    Tumor Cell Vaccines        6.4.1
  Market Trends        6.4.2 Market Forecast7  
  Market Breakup by Disease Type    7.1  
   Autoimmune Disease Vaccines        7.1.1 Market
  Trends        7.1.2 Market Forecast    7.2  
   Addiction Vaccine        7.2.1 Market Trends 
        7.2.2 Market Forecast    7.3  
   Neurological Disease Vaccine        7.3.1
  Market Trends        7.3.2 Market Forecast   
  7.4    Infectious Disease Vaccine        7.4.1
  Market Trends        7.4.2 Market Forecast   
  7.5    Others        7.5.1 Market Trends       
  7.5.2 Market Forecast8   Market Breakup by
  Technology    8.1    Autologous Vaccines       
  8.1.1 Market Trends        8.1.2 Market
  Forecast    8.2    Allogeneic Vaccine       
  8.2.1 Market Trends        8.2.2 Market Forecast
  
• For more information, visit https//www.imarcgrou
  p.com/therapeutic-vaccines-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com